"Biopsy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Removal and pathologic examination of specimens from the living body.
| Descriptor ID |
D001706
|
| MeSH Number(s) |
E01.370.225.500.384.100 E01.370.225.998.054 E01.370.388.100 E04.074 E05.200.500.384.100 E05.200.998.054 E05.242.384.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Biopsy".
Below are MeSH descriptors whose meaning is more specific than "Biopsy".
This graph shows the total number of publications written about "Biopsy" by people in this website by year, and whether "Biopsy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 24 | 26 |
| 1997 | 0 | 20 | 20 |
| 1998 | 1 | 9 | 10 |
| 1999 | 2 | 13 | 15 |
| 2000 | 0 | 10 | 10 |
| 2001 | 1 | 21 | 22 |
| 2002 | 0 | 13 | 13 |
| 2003 | 2 | 18 | 20 |
| 2004 | 3 | 16 | 19 |
| 2005 | 1 | 15 | 16 |
| 2006 | 0 | 26 | 26 |
| 2007 | 3 | 26 | 29 |
| 2008 | 2 | 24 | 26 |
| 2009 | 2 | 38 | 40 |
| 2010 | 2 | 22 | 24 |
| 2011 | 1 | 27 | 28 |
| 2012 | 5 | 24 | 29 |
| 2013 | 2 | 33 | 35 |
| 2014 | 2 | 37 | 39 |
| 2015 | 3 | 46 | 49 |
| 2016 | 5 | 37 | 42 |
| 2017 | 0 | 48 | 48 |
| 2018 | 2 | 46 | 48 |
| 2019 | 2 | 44 | 46 |
| 2020 | 1 | 44 | 45 |
| 2021 | 1 | 31 | 32 |
| 2022 | 1 | 10 | 11 |
| 2023 | 0 | 19 | 19 |
| 2024 | 0 | 24 | 24 |
| 2025 | 0 | 11 | 11 |
| 2026 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biopsy" by people in Profiles.
-
Noninvasive Detection of Occult yet Significant Liver Pathology in Alanine Aminotransferase-Normal Chronic Hepatitis B: A Multicenter Study. J Infect Dis. 2026 Mar 17; 233(3):528-540.
-
Assessment of non-invasive fibrosis scoring systems in pediatric MASLD: A retrospective comparison across healthy, MASLD, and biopsy-staged groups. Clin Chim Acta. 2026 Apr 15; 586:120905.
-
Liver Biopsy Features May Help Distinguish Drug-Induced Autoimmune-Like Hepatitis From Idiopathic Autoimmune Hepatitis. Arch Pathol Lab Med. 2026 Jan 14; 150(6):448-456.
-
A case of chronic Campylobacter fetus infection-related glomerulonephritis, mimicking systemic autoimmune diseases. CEN Case Rep. 2026 Jan 13; 15(1):18.
-
Performance of Ulcer Features in Predicting Malignancy Among Gastric Ulcers Diagnosed on Upper Endoscopy. J Clin Gastroenterol. 2026 Jan 01; 60(1):40-46.
-
Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease. J Gastrointestin Liver Dis. 2025 12 26; 34(4):437-450.
-
Assessment of Skin in Patients With Systemic Sclerosis Using High-Frequency Ultrasound and Shear Wave Elastography: A Comparative Study With Histology, Molecular, and Clinical Parameters. Arthritis Care Res (Hoboken). 2026 May; 78(5):582-590.
-
AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus. Gastroenterology. 2025 11; 169(6):1184-1231.
-
Corrected T1 (cT1) is the most appropriate diagnosis and monitoring tool for widespread adoption of resmetirom treatment in the United States. J Med Econ. 2025 Dec; 28(1):1370-1387.
-
The Safety of Pulsed Electric Field Ablation Before Standard of Care Treatment for Patients With Metastatic Cancer. J Bronchology Interv Pulmonol. 2025 Oct 01; 32(4).